Member of the Board since 2023.

M.Sc. in Chemical biology. Elin has worked at the university (KTH) and pharma and biotech industry since 2012 and has experience in antibody discovery and high-throughput analysis. Born 1985.

Other board appointments: -

Shareholding: 92 (affiliated holdings)

Conditional Employee Options: Option program 2022/2024: 3,099; option program 2023/2025: 1,266; option program 2024/2026: 498

/sites/bioinvent/files/Elin-Birgersson_webb-2023_2_0_369x370.jpg Employee representative Board of Directors Off http://twitter.com/ http://linkedin.com/